|
Volumn 58, Issue 11, 2011, Pages
|
Modern treatment strategies in rheumatoid arthritis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BETAMETHASONE;
CYCLOSPORIN;
IMMUNOGLOBULIN G;
METHOTREXATE;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
AGED;
ARTICLE;
COHORT ANALYSIS;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
INTRAARTICULAR DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REMISSION;
RHEUMATOID ARTHRITIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BETAMETHASONE;
COHORT STUDIES;
CYCLOSPORINE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
INJECTIONS, INTRA-ARTICULAR;
MALE;
METHOTREXATE;
MIDDLE AGED;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTORS, TUMOR NECROSIS FACTOR;
REMISSION INDUCTION;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84875483161
PISSN: None
EISSN: 16039629
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|